PTGS2 and neoplasm: Inflammatory cells release some cytokines, such as COX-2, EGF and VEGF, which are the effectors of tumor tissue promotion; an alteration of immunity cells, both in number and in function, at sites of tumor progression is the generic constituent of the tumor microenvironment [24].